Novavax Covid-19 Vaccine Gets CDC Green Light

The Novavax Covid-19 vaccine was approved by the CDC a few days ago. University of Iowa Health Care was one of the sites in the multi-site Phase 3 trial.

The vaccine is not based on mRNA technology; it uses a more traditional method similar to the flu vaccine, which is familiar to more people.

FDA Advisory Committee Green Lights Novavax Covid-19 Vaccine

The FDA Advisory Committee endorsed the Novavax Covid-19 Vaccine at their meeting June 7, 2022. It awaits the FDA Director’s decision and, if endorsed by the director, would next go to the CDC Advisory Committee for their evaluation, which looks like it might be scheduled later this month.